These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
377 related articles for article (PubMed ID: 33459640)
21. Argyrophilic grains are not always argyrophilic--distinction from neurofibrillary tangles of diffuse neurofibrillary tangles with calcification revealed by comparison between Gallyas and Campbell-Switzer methods. Uchihara T; Tsuchiya K; Nakamura A; Akiyama H Acta Neuropathol; 2005 Aug; 110(2):158-64. PubMed ID: 15971055 [TBL] [Abstract][Full Text] [Related]
22. Neurofibrillary degeneration in progressive supranuclear palsy and corticobasal degeneration: tau pathologies with exclusively "exon 10" isoforms. Sergeant N; Wattez A; Delacourte A J Neurochem; 1999 Mar; 72(3):1243-9. PubMed ID: 10037497 [TBL] [Abstract][Full Text] [Related]
23. The Role of Tau Proteoforms in Health and Disease. Waheed Z; Choudhary J; Jatala FH; Fatimah ; Noor A; Zerr I; Zafar S Mol Neurobiol; 2023 Sep; 60(9):5155-5166. PubMed ID: 37266762 [TBL] [Abstract][Full Text] [Related]
25. Regional quantitative analysis of tau-positive neurons in progressive supranuclear palsy: comparison with Alzheimer's disease. Li F; Iseki E; Odawara T; Kosaka K; Yagishita S; Amano N J Neurol Sci; 1998 Jul; 159(1):73-81. PubMed ID: 9700707 [TBL] [Abstract][Full Text] [Related]
26. Progressive supranuclear palsy: extensive neuropil threads in addition to neurofibrillary tangles. Very similar antigenicity of subcortical neuronal pathology in progressive supranuclear palsy and Alzheimer's disease. Probst A; Langui D; Lautenschlager C; Ulrich J; Brion JP; Anderton BH Acta Neuropathol; 1988; 77(1):61-8. PubMed ID: 3149122 [TBL] [Abstract][Full Text] [Related]
27. Human tau pathology transmits glial tau aggregates in the absence of neuronal tau. Narasimhan S; Changolkar L; Riddle DM; Kats A; Stieber A; Weitzman SA; Zhang B; Li Z; Roberson ED; Trojanowski JQ; Lee VMY J Exp Med; 2020 Feb; 217(2):. PubMed ID: 31826239 [TBL] [Abstract][Full Text] [Related]
28. Phosphorylated protein kinases associated with neuronal and glial tau deposits in argyrophilic grain disease. Ferrer I; Barrachina M; Tolnay M; Rey MJ; Vidal N; Carmona M; Blanco R; Puig B Brain Pathol; 2003 Jan; 13(1):62-78. PubMed ID: 12580546 [TBL] [Abstract][Full Text] [Related]
29. Tau protein profiling in tauopathies: a human brain study. Lantero-Rodriguez J; Camporesi E; Montoliu-Gaya L; Gobom J; Piotrowska D; Olsson M; Burmann IM; Becker B; Brinkmalm A; Burmann BM; Perkinton M; Ashton NJ; Fox NC; Lashley T; Zetterberg H; Blennow K; Brinkmalm G Mol Neurodegener; 2024 Jul; 19(1):54. PubMed ID: 39026372 [TBL] [Abstract][Full Text] [Related]
30. Tau epitope display in progressive supranuclear palsy and corticobasal degeneration. Berry RW; Sweet AP; Clark FA; Lagalwar S; Lapin BR; Wang T; Topgi S; Guillozet-Bongaarts AL; Cochran EJ; Bigio EH; Binder LI J Neurocytol; 2004 May; 33(3):287-95. PubMed ID: 15475684 [TBL] [Abstract][Full Text] [Related]
31. Properties of antigenic determinants that distinguish neurofibrillary tangles in progressive supranuclear palsy and Alzheimer's disease. Schmidt ML; Lee VM; Hurtig H; Trojanowski JQ Lab Invest; 1988 Oct; 59(4):460-6. PubMed ID: 2459498 [TBL] [Abstract][Full Text] [Related]
32. Phosphorylated c-MYC expression in Alzheimer disease, Pick's disease, progressive supranuclear palsy and corticobasal degeneration. Ferrer I; Blanco R; Carmona M; Puig B Neuropathol Appl Neurobiol; 2001 Oct; 27(5):343-51. PubMed ID: 11679086 [TBL] [Abstract][Full Text] [Related]
33. Corticobasal degeneration: a disease with widespread appearance of abnormal tau and neurofibrillary tangles, and its relation to progressive supranuclear palsy. Mori H; Nishimura M; Namba Y; Oda M Acta Neuropathol; 1994; 88(2):113-21. PubMed ID: 7985491 [TBL] [Abstract][Full Text] [Related]
34. Association of CD2AP neuronal deposits with Braak neurofibrillary stage in Alzheimer's disease. Camacho J; Rábano A; Marazuela P; Bonaterra-Pastra A; Serna G; Moliné T; Ramón Y Cajal S; Martínez-Sáez E; Hernández-Guillamon M Brain Pathol; 2022 Jan; 32(1):e13016. PubMed ID: 34514662 [TBL] [Abstract][Full Text] [Related]
35. Tau accumulation in astrocytes in progressive supranuclear palsy is a degenerative rather than a reactive process. Togo T; Dickson DW Acta Neuropathol; 2002 Oct; 104(4):398-402. PubMed ID: 12200627 [TBL] [Abstract][Full Text] [Related]
36. Relationship of the extended tau haplotype to tau biochemistry and neuropathology in progressive supranuclear palsy. Liu WK; Le TV; Adamson J; Baker M; Cookson N; Hardy J; Hutton M; Yen SH; Dickson DW Ann Neurol; 2001 Oct; 50(4):494-502. PubMed ID: 11601500 [TBL] [Abstract][Full Text] [Related]
37. SUMO1 Modification of Tau in Progressive Supranuclear Palsy. Takamura H; Nakayama Y; Ito H; Katayama T; Fraser PE; Matsuzaki S Mol Neurobiol; 2022 Jul; 59(7):4419-4435. PubMed ID: 35567706 [TBL] [Abstract][Full Text] [Related]
38. Phosphorylation and cleavage of tau in non-AD tauopathies. Guillozet-Bongaarts AL; Glajch KE; Libson EG; Cahill ME; Bigio E; Berry RW; Binder LI Acta Neuropathol; 2007 May; 113(5):513-20. PubMed ID: 17357802 [TBL] [Abstract][Full Text] [Related]
39. Hypersialylation is a common feature of neurofibrillary tangles and granulovacuolar degenerations in Alzheimer's disease and tauopathy brains. Nagamine S; Yamazaki T; Makioka K; Fujita Y; Ikeda M; Takatama M; Okamoto K; Yokoo H; Ikeda Y Neuropathology; 2016 Aug; 36(4):333-45. PubMed ID: 26685795 [TBL] [Abstract][Full Text] [Related]
40. Phosphorylation of specific sets of tau isoforms reflects different neurofibrillary degeneration processes. Mailliot C; Sergeant N; Bussière T; Caillet-Boudin ML; Delacourte A; Buée L FEBS Lett; 1998 Aug; 433(3):201-4. PubMed ID: 9744794 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]